Nonetheless, the authors concluded, “Liver biopsy is considered the gold standard for diagnosing MASH and MASLD. While ...

Metabolic dysfunction-associated steatotic liver disease (MASLD), affecting approximately 30% of the global population, represents a spectrum of liver disorders ranging from simple steatosis to ...

Individuals with metabolic dysfunction-associated steatotic liver disease (MASLD) had a higher rate of appearance of oral glucose — particularly during the first hour after a glucose load — and higher ...

Globally more than 30% of the adult population has metabolic dysfunction-associated steatotic liver disease (MASLD). People with MASLD and more so with metabolic dysfunction-associated steatohepatitis ...

Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease worldwide. Epidemiological evidence indicates that MASLD is associated with an ...

The Food Inflammation Index (FII) shows a significant linear relationship with MASLD risk, outperforming the Dietary Inflammatory Index (DII) in assessing dietary inflammatory potential. Higher FII ...

SAN DIEGO -- A new blood test can predict the development of metabolic dysfunction-associated steatotic liver disease (MASLD) up to 16 years before it occurs, according to a retrospective cohort study ...

Familial Hypobetalipoproteinemia (FHBL), caused by variants in the apolipoprotein B (APOB) gene, is a rare autosomal co-dominant monogenic disorder characterized by lifelong low plasma levels of total ...

WASHINGTON -- A large percentage of people with metabolic dysfunction-associated steatotic liver disease (MASLD) had their liver fat content normalize with an investigational dual agonist of the GLP-1 ...

MASLD/MASH patients have increased cardiovascular risks, necessitating regular risk assessments and interventions. Lifestyle changes, such as diet and exercise, are vital for managing cardiovascular ...